NeuroSave is a clinical-stage medical device company focused on preventing and treating ischemic brain injury caused by surgery, cardiac arrest, stroke, or trauma. The company aims to deliver therapeutic hypothermia to the brain while mitigating the negative effects of cooling on the body. NeuroSave's innovative therapy circulates cold fluid in the aerodigestive tract to cool blood in the arteries traveling to the brain, ensuring rapid brain-targeted cooling.
NeuroSave has made significant strides in the field of therapeutic hypothermia, positioning itself as a leader in ischemic brain injury prevention. The company's technology has the potential to revolutionize emergency and surgical care by providing a rapid and targeted cooling solution. NeuroSave's advancements have garnered attention from the medical community, highlighting its impact on improving patient outcomes in critical care scenarios.
